HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Lunec Selected Research

Fibrosis (Cirrhosis)

1/2021Key features of the environment promoting liver cancer in the absence of cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Lunec Research Topics

Disease

24Neoplasms (Cancer)
04/2024 - 07/2003
15Neuroblastoma
01/2019 - 07/2003
3Ovarian Neoplasms (Ovarian Cancer)
02/2024 - 06/2016
3Osteosarcoma (Osteogenic Sarcoma)
02/2021 - 03/2012
3Sarcoma (Soft Tissue Sarcoma)
05/2014 - 03/2005
2Adenocarcinoma
01/2022 - 07/2021
2Neoplasm Metastasis (Metastasis)
02/2021 - 08/2014
2Melanoma (Melanoma, Malignant)
12/2018 - 01/2018
2Prostatic Neoplasms (Prostate Cancer)
11/2016 - 06/2007
1Leukemia
04/2024
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2023
1Disease Resistance
07/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022
1Hepatitis
10/2021
1Carcinoma (Carcinomatosis)
02/2021
1Hypoxia (Hypoxemia)
02/2021
1Fibrosis (Cirrhosis)
01/2021
1Inflammation (Inflammations)
01/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2020
1Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015
1Metabolic Diseases (Metabolic Disease)
12/2012
1Mesothelioma
06/2009
1Malignant Mesothelioma
06/2009

Drug/Important Bio-Agent (IBA)

11RG7388IBA
04/2024 - 04/2015
7nutlin 3IBA
02/2024 - 06/2007
6Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2019
4Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2012
3Dihydroorotate DehydrogenaseIBA
08/2023 - 01/2018
3GSK2830371IBA
01/2022 - 01/2018
3RNA (Ribonucleic Acid)IBA
10/2021 - 09/2007
3siremadlinIBA
07/2021 - 01/2018
3Tumor Suppressor Protein p14ARF (p14ARF)IBA
04/2015 - 02/2006
3Messenger RNA (mRNA)IBA
01/2013 - 07/2003
2rucaparibIBA
02/2024 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
09/2023 - 07/2003
2Matrix Metalloproteinases (MMPs)IBA
02/2021 - 07/2003
2NucleotidesIBA
01/2020 - 04/2019
2Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 04/2015
2Androgen Receptors (Androgen Receptor)IBA
11/2016 - 06/2007
2Cisplatin (Platino)FDA LinkGeneric
06/2016 - 04/2015
2Pemetrexed (MTA)FDA Link
09/2015 - 12/2009
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2013 - 11/2007
2N-acetyltalosaminuronic acid (NAT)IBA
12/2012 - 08/2003
2Transcription Factors (Transcription Factor)IBA
07/2010 - 07/2003
2LuciferasesIBA
03/2008 - 07/2003
23- (4- chlorophenyl)- 3- (4- hydroxy- 3,5- dimethoxybenzyloxy)- 2- propyl- 2,3- dihydroisoindol- 1- oneIBA
10/2006 - 03/2005
1navitoclaxIBA
04/2024
1adavosertibIBA
09/2023
1Phosphotransferases (Kinase)IBA
09/2023
1Retroelements (Retrotransposon)IBA
01/2023
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2021
1Oxygen (Dioxygen)IBA
02/2021
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
02/2021
1LigandsIBA
01/2021
1AntioxidantsIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1GemcitabineFDA Link
10/2020
1ProdrugsIBA
01/2019
1RO6839921IBA
01/2019
1trametinibIBA
12/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2018
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2018
1Keratins (Keratin)IBA
01/2018
1Coloring Agents (Dyes)IBA
01/2018
1VimentinIBA
01/2018
1Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2016
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
05/2016
1Adenosine Diphosphate (ADP)IBA
05/2016
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2016
1Lapatinib (GW572016)FDA Link
09/2015
1Thymidylate SynthaseIBA
09/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2015
1Topotecan (Hycamtin)FDA LinkGeneric
04/2015
1Busulfan (Busulfex)FDA Link
04/2015
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2014
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2014
1Celecoxib (Celebrex)FDA Link
08/2014
1RG7112IBA
05/2014
1Fatty Acids (Saturated Fatty Acids)IBA
12/2012
1Glucose (Dextrose)FDA LinkGeneric
12/2012
1Glutamine (L-Glutamine)FDA Link
12/2012
1Folic Acid AntagonistsIBA
12/2009
1Indicators and Reagents (Reagents)IBA
12/2009
1vatalanib (PTK787)IBA
06/2009
1Tyrosine Kinase InhibitorsIBA
06/2009
1Sunitinib (Sutent)FDA Link
06/2009
1Gefitinib (Iressa)FDA Link
06/2009
1vandetanib (ZD6474)IBA
06/2009

Therapy/Procedure

18Therapeutics
04/2024 - 07/2003
9Drug Therapy (Chemotherapy)
10/2020 - 07/2003
2Drug Tapering
02/2024 - 01/2017
2Ligation
02/2021 - 02/2011
1Oral Administration
01/2021
1Molecular Targeted Therapy
01/2019
1Immunotherapy
03/2018